Gene · 7033
Papers3,041
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
661 to 680 of 3,041
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Multi-Omics Analyses to Identify FCGBP as a Potential Predictor in Head and Neck Squamous Cell Carcinoma. | Diagnostics (Basel) | 2022 | 35626334 | PubTator, text mining | PubMed |
| Constraint-Based, Score-Based and Hybrid Algorithms to Construct Bayesian Gene Networks in the Bovine Transcriptome. | Animals (Basel) | 2022 | 35625151 | PubTator, text mining | PubMed |
| The Role of Proprotein Convertases in Upper Airway Remodeling. | Mol Cells | 2022 | 35611689 | PubTator, text mining | PubMed |
| Genetically regulated gene expression and proteins revealed discordant effects. | PLoS One | 2022 | 35604899 | PubTator, text mining | PubMed |
| The Role and Function of Mucins and Its Relationship to Inflammatory Bowel Disease. | Front Med (Lausanne) | 2022 | 35602503 | PubTator, text mining | PubMed |
| Noninvasive urinary protein signatures associated with colorectal cancer diagnosis and metastasis. | Nat Commun | 2022 | 35589723 | PubTator, text mining | PubMed |
| Integration of human inspection and artificial intelligence-based morphological typing of patient-derived organoids reveals interpatient heterogeneity of colorectal cancer. | Cancer Sci | 2022 | 35585758 | PubTator, text mining | PubMed |
| Impact of the Tumor Microenvironment for Esophageal Tumor Development-An Opportunity for Prevention? | Cancers (Basel) | 2022 | 35565378 | PubTator, text mining | PubMed |
| Proteomics in Multiple Sclerosis: The Perspective of the Clinician. | Int J Mol Sci | 2022 | 35563559 | PubTator, text mining | PubMed |
| Single-cell sequencing reveals the heterogeneity and intratumoral crosstalk in human endometrial cancer. | Cell Prolif | 2022 | 35560676 | PubTator, text mining | PubMed |
| A 13-Gene Signature Based on Estrogen Response Pathway for Predicting Survival and Immune Responses of Patients With UCEC. | Front Mol Biosci | 2022 | 35558564 | PubTator, text mining | PubMed |
| SCN1A overexpression, associated with a genomic region marked by a risk variant for a common epilepsy, raises seizure susceptibility. | Acta Neuropathol | 2022 | 35551471 | PubTator, text mining | PubMed |
| A Mass Spectrometric Approach to the Proteomic Profiling of the Canis lupus familiaris Acquired Enamel Pellicle on Hydroxyapatite Discs. | J Vet Dent | 2022 | 35549755 | PubTator, text mining | PubMed |
| X-box binding protein 1 (XBP1): a potential role in chemotherapy response, clinical pathologic features, non-inflamed tumour microenvironment for breast cancer. | Biosci Rep | 2022 | 35543228 | PubTator, text mining | PubMed |
| A p300/GATA6 axis determines differentiation and Wnt dependency in pancreatic cancer models. | J Clin Invest | 2022 | 35536676 | PubTator, text mining | PubMed |
| Ulcerative Colitis: Novel Epithelial Insights Provided by Single Cell RNA Sequencing. | Front Med (Lausanne) | 2022 | 35530046 | PubTator, text mining | PubMed |
| Nanofiber capsules for minimally invasive sampling of biological specimens from gastrointestinal tract. | Acta Biomater | 2022 | 35513306 | PubTator, text mining | PubMed |
| Taxonomical and functional changes in COVID-19 faecal microbiome could be related to SARS-CoV-2 faecal load. | Environ Microbiol | 2022 | 35506300 | PubTator, text mining | PubMed |
| Olive Leaves as a Potential Phytotherapy in the Treatment of COVID-19 Disease; A Mini-Review. | Front Pharmacol | 2022 | 35496299 | PubTator, text mining | PubMed |
| The role of nucleoside triphosphate hydrolase metallochaperones in making metalloenzymes. | Metallomics | 2022 | 35485745 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7033/papers?page=34